As an NCI-designated cancer center, the Dan L Duncan Comprehensive Cancer Center at Baylor St.
Luke's is part of an elite group of 70 cancer research institutions in the United States. We o!er
personalized medicine where specialists use the patient's genetic makeup to help pinpoint the
proper course of therapy, targeting the speci"c characteristics unique to the cancer. Additionally,
many of our innovative cancer treatments stem from our own nationally recognized research. That's
our answer to cancer.